This inventor holds 1 USPTO granted patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Karsten Guelow: Innovator in Reactive Oxygen Species Treatment
Introduction
Karsten Guelow is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of diseases caused by reactive oxygen species (ROS). His innovative approach has the potential to impact the lives of many patients suffering from inflammatory diseases.
Latest Patents
Karsten Guelow holds a patent for "Methods and compounds for treating diseases caused by reactive oxygen species." This patent outlines a method for treating patients with inflammatory diseases by utilizing a compound that inhibits complex I-mediated ROS production. The patent also includes a medicament containing such a compound and methods for screening for these compounds. He has 1 patent to his name.
Career Highlights
Guelow is affiliated with the Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts, where he conducts his research. His work focuses on developing effective treatments for diseases linked to oxidative stress, showcasing his commitment to advancing medical science.
Collaborations
Throughout his career, Karsten Guelow has collaborated with esteemed colleagues, including Marcin Kaminski and Michael Kiessling. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Karsten Guelow's contributions to the field of medical research, particularly in the treatment of diseases caused by reactive oxygen species, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments that can improve patient outcomes.